We are live on ! Find out more
SP

Sage Partners Portfolio holdings

AUM $23K
This Fund
S&P 500
This Quarter Est. Return
-65.73%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$33K
AUM Growth
-$12.9M
Cap. Flow
-$8.55M
Cap. Flow %
-25,923.1%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
1
Closed
2

Top Buys

No buys this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBP
1
NovaBridge Biosciences American Depositary Shares
NBP
$185M
$33K 100%
2,054
-197,946
-99% -$5.07M
BNR
2
Burning Rock Biotech
BNR
$93.9M
-17,440
Closed -$1.66M
ZLAB icon
3
Zai Lab
ZLAB
$2.06B
-28,952
Closed -$1.82M

Similar funds

Sage Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Sage Partners held 3 positions worth $33K, down 100% from $13M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Sage Partners withdrew a net $8.55M in Q1 2022, closing 2 positions and reducing 1 holding. Its most notable exit was Zai Lab, an estimated $1.82M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Sage Partners's biggest Q1 2022 reduction was NovaBridge Biosciences American Depositary Shares, cutting an estimated $5.07M.
  • Sage Partners fully exited Zai Lab in Q1 2022, selling an estimated $1.82M.
  • Sage Partners's ten largest holdings make up 100% of its $33K portfolio in Q1 2022.
  • Sage Partners opened 0 new positions and closed 2 in Q1 2022.
  • Sage Partners's portfolio value fell 100% quarter-over-quarter to $33K.

Based on Sage Partners's 13F filing for Q1 2022, filed 4 May 2022.